We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$14.4B
AUM Growth
+$580M
Cap. Flow
-$102M
Cap. Flow %
-0.7%
Top 10 Hldgs %
30.89%
Holding
368
New
16
Increased
155
Reduced
158
Closed
9

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$64.6M
2
LLY icon
Eli Lilly
LLY
+$31.3M
3
MDLZ icon
Mondelez International
MDLZ
+$25.7M
4
AVGO icon
Broadcom
AVGO
+$21.7M
5
PSX icon
Phillips 66
PSX
+$11.8M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$45.1M
2
HPQ icon
HP
HPQ
+$40M
3
NEE icon
NextEra Energy
NEE
+$33M
4
PAYX icon
Paychex
PAYX
+$25.1M
5
CSCO icon
Cisco
CSCO
+$19.9M

Sector Composition

Rank Sector Weight
1 Technology 19.25%
2 Financials 16.25%
3 Healthcare 12.13%
4 Consumer Staples 10.11%
5 Industrials 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
51
Stryker
SYK
$131B
$73.4M 0.51%
349,563
-8,694
-2% -$1.8M
CTAS icon
52
Cintas
CTAS
$81.6B
$69.8M 0.48%
1,037,636
-8,224
-0.8% -$541K
DRI icon
53
Darden Restaurants
DRI
$23.6B
$68.2M 0.47%
626,014
+10,732
+2% +$1.22M
WMB icon
54
Williams Companies
WMB
$86.1B
$65.5M 0.45%
2,763,053
-79,701
-3% -$1.83M
NOC icon
55
Northrop Grumman
NOC
$77.9B
$65.3M 0.45%
189,941
+29,211
+18% +$10.3M
CINF icon
56
Cincinnati Financial
CINF
$27.3B
$63.7M 0.44%
605,896
-14,265
-2% -$1.56M
ABBV icon
57
AbbVie
ABBV
$433B
$61.7M 0.43%
697,405
-99,187
-12% -$8.23M
BAC icon
58
Bank of America
BAC
$440B
$60.5M 0.42%
1,717,074
+60,656
+4% +$1.96M
OKE icon
59
Oneok
OKE
$55.6B
$57.1M 0.4%
754,395
-4,465
-0.6% -$319K
NKE icon
60
Nike
NKE
$61.6B
$54.7M 0.38%
540,392
-18,793
-3% -$1.77M
TGT icon
61
Target
TGT
$67.8B
$54.7M 0.38%
426,451
-69,618
-14% -$8.17M
BAX icon
62
Baxter International
BAX
$14.5B
$54.4M 0.38%
650,205
-3,591
-0.5% -$297K
ETN icon
63
Eaton
ETN
$173B
$53.6M 0.37%
566,135
-17,233
-3% -$1.53M
INTC icon
64
Intel
INTC
$509B
$53.6M 0.37%
894,811
-19,479
-2% -$1.09M
UNH icon
65
UnitedHealth
UNH
$370B
$52.3M 0.36%
177,863
-30,245
-15% -$7.91M
TJX icon
66
TJX Companies
TJX
$174B
$50.3M 0.35%
824,232
+34,221
+4% +$2.02M
MKTX icon
67
MarketAxess Holdings
MKTX
$5.71B
$45.2M 0.31%
119,150
-10,523
-8% -$3.86M
WSO icon
68
Watsco Inc
WSO
$13.1B
$42.1M 0.29%
233,838
+9,329
+4% +$1.64M
AMT icon
69
American Tower
AMT
$80.6B
$42M 0.29%
182,952
+1,579
+0.9% +$344K
BDX icon
70
Becton Dickinson
BDX
$46.9B
$40.9M 0.28%
154,209
-2,906
-2% -$724K
ECL icon
71
Ecolab
ECL
$78.6B
$35.8M 0.25%
185,663
-1,198
-0.6% -$227K
RTX icon
72
RTX Corp
RTX
$292B
$35.5M 0.25%
376,340
-14,022
-4% -$1.27M
MKC icon
73
McCormick & Company Non-Voting
MKC
$13.9B
$33.7M 0.23%
396,640
-110,346
-22% -$9.13M
ATO icon
74
Atmos Energy
ATO
$28.9B
$33.5M 0.23%
299,479
-8,713
-3% -$956K
D icon
75
Dominion Energy
D
$60.5B
$29.6M 0.21%
357,646
-38,778
-10% -$3.17M

Similar funds

Bahl & Gaynor's Q4 2019 Portfolio in Review

As of Q4 2019, Bahl & Gaynor held 368 positions worth $14.4B, up 4.2% from $13.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2019 filing shows 16 new, 155 increased, 158 reduced and 9 closed positions. Its largest new stake was Penske Automotive Group: 54,533 shares worth $2.74M. The largest sale was Pfizer, an estimated $45.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q4 2019 buy was Penske Automotive Group: 54,533 shares worth $2.74M.
  • Bahl & Gaynor added most to Automatic Data Processing in Q4 2019, an estimated $64.6M increase.
  • Bahl & Gaynor's biggest Q4 2019 reduction was Pfizer, cutting an estimated $45.1M.
  • Bahl & Gaynor fully exited KLA in Q4 2019, selling an estimated $3.18M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $14.4B portfolio in Q4 2019.
  • Bahl & Gaynor opened 16 new positions and closed 9 in Q4 2019.
  • Bahl & Gaynor's portfolio value rose 4.2% quarter-over-quarter to $14.4B.

Based on Bahl & Gaynor's 13F filing for Q4 2019, filed 14 Feb 2020.